Rheosorbilact®
Rheosorbilact® is a national scientific asset, since it was developed by Ukrainian professionals.
This is one of the most balanced solutions: rational combination of components complementing and potentiating each other’s action; the product provides comprehensive pharmacological effects.
All components have iso-osmotic concentrations, which minimizes side effects and provides osmolality by three times higher than that of blood plasma (0.9 vs. 0.29 osmol/l) in aggregate.
The solution’s hyperosmolalilty provides expressed detoxification effect and potent hemodynamic action, improves blood microcirculation and rheology.
After invention of Rheosorbilact®, a multicomponent polyfunctional solution, it became clear that monocomponent solutions (5 % glucose solution, 0.9 % sodium chloride solution) are increasingly becoming history.
RHEOSORBILACT® is the basis for contemporary treatment of internal diseases: small volume infusion therapy.
How supplied
200 ml
400 ml
Sales markets
Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uganda, Uzbekistan, Ukraine.
Articles
- The first results of the international multicenter clinical study RheoSTAT-CP0669 on the effectiveness and safety of infusion solution Rheosorbilact® in the complex treatment of patients with burns
- The modern aspects of the optimal therapeutic strategy of hyperemesis gravidarum
- The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis
- The first data on international multicenter clinical study RheoSTAT-CP0620 on the efficacy and safety of Rheosorbilact® infusion in therapy of sepsis
- The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia
- Methods of Correction of Neurological Disorders in Patients with Coronavirus Disease (COVID-19)
- Modern approaches to the correction of hemodynamic disorders in patients with severe combined trauma
- Rheosorbilact: detoxifying properties and effects of this drug on hemostasis
- Healthy nephrone — a guaranty of stable blood pressure
- Rheosorbilact improves the efficacy of empirical therapy for pelvic inflammatory disease (a case report)
- The ways to ameliorate the efficiency of treatment for women with pelvic inflammatory disease
- Safety and effectiveness of Rheosorbilact detoxification therapy in stage 1–3 CKD
- The first data on international multicenter clinical study RheoSTAT on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia
- Balanced solutions in infusion therapy for acute pancreatitis: practice-proven efficacy
